Suppr超能文献

撒哈拉以南非洲地区5岁以下发热/咳嗽儿童的抗生素处方来源及使用情况。

Antibiotic prescription sources and use among under-5 children with fever/cough in sub-Saharan Africa.

作者信息

Tesema Getayeneh A, Biney Godness K, Wang Vicky Q, Ameyaw Edward K, Yaya Sanni

机构信息

Department of Epidemiology and Biostatistics, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA.

出版信息

Int Health. 2025 Jan 3;17(1):94-104. doi: 10.1093/inthealth/ihae026.

Abstract

BACKGROUND

Childhood febrile illness is among the leading causes of hospital admission for children <5 y of age in sub-Saharan Africa (SSA). Antibiotics have played a pivotal role in enhancing health outcomes, especially for children <5 y of age. Antibiotics prescription pattern evidence exists for SSA, however, prescription sources (either from qualified or unqualified sources) and use among children with fever or cough have not been explored. Thus the present study assessed antibiotic prescription sources and use among children <5 y of age with fever and cough in SSA.

METHODS

We used Demographic and Health Survey data from 37 countries with a total of 18 866 children <5 y of age who had fever/cough. The surveys span from 2006 to 2021. The dependent variable was antibiotics taken for fever/cough based on prescriptions from qualified sources. The data were weighted using sampling weight, primary sampling unit and strata. A mixed-effects logistic regression model (both fixed and random effects) was fitted since the outcome variable was binary. Model comparison was made based on deviance (-2 log likelihood) and likelihood ratio tests were used for model comparison. Variables with p≤0.2 in the bivariable analysis were considered for the multivariable mixed-effects binary logistic regression model. In the final model, the adjusted odds ratio (AOR) with a 95% confidence interval (CI) and p<0.05 in the multivariable model were used to declare a significant association with taking antibiotics for fever/cough prescribed from qualified sources.

RESULTS

The percentage of unqualified antibiotic prescriptions among children <5 y of age who had a fever/cough and took antibiotics was 67.19% (95% CI 66.51 to 67.85), ranging from 40.34% in Chad to 92.67% in Sao Tome. The odds of taking antibiotics prescribed from unqualified sources for fever/cough among children <5 y of age living in rural areas were 1.23 times higher (AOR 1.23 [95% CI 1.13 to 1.33]) compared with urban children. The odds of taking antibiotics prescribed from qualified sources for fever/cough among children <5 y of age whose mothers had primary, secondary and higher education decreased by 14% (AOR=0.86 [95% CI 0.79 to 0.93]), 21% (AOR 0.79 [95% CI 0.72 to 0.86]) and 21% (AOR 0.79 [95% CI 0.65 to 0.95]) compared with those whose mother had no formal education, respectively.

CONCLUSIONS

The study showed that the majority of the children who received antibiotics obtained them from unqualified sources in the 37 SSA countries. Our findings underscore the significance of addressing healthcare disparities, improving access to qualified healthcare providers, promoting maternal education and empowering mothers in healthcare decision-making to ensure appropriate antibiotic use in this vulnerable population. Further research and interventions targeted at these factors are warranted to optimize antibiotic prescribing practices and promote responsible antibiotic use in the management of fever and cough in children <5 y of age.

摘要

背景

儿童发热性疾病是撒哈拉以南非洲(SSA)5岁以下儿童住院的主要原因之一。抗生素在改善健康结局方面发挥了关键作用,尤其是对于5岁以下的儿童。SSA存在抗生素处方模式的证据,然而,处方来源(合格或不合格来源)以及发热或咳嗽儿童的使用情况尚未得到研究。因此,本研究评估了SSA中5岁以下发热和咳嗽儿童的抗生素处方来源及使用情况。

方法

我们使用了来自37个国家的人口与健康调查数据,共有18866名5岁以下发热/咳嗽儿童。调查时间跨度为2006年至2021年。因变量是根据合格来源的处方服用的用于发热/咳嗽的抗生素。数据使用抽样权重、初级抽样单位和分层进行加权。由于结果变量是二元的,因此拟合了混合效应逻辑回归模型(固定效应和随机效应)。基于偏差(-2对数似然)进行模型比较,并使用似然比检验进行模型比较。在多变量混合效应二元逻辑回归模型中考虑双变量分析中p≤0.2的变量。在最终模型中,多变量模型中具有95%置信区间(CI)且p<0.05的调整优势比(AOR)用于表明与服用合格来源处方的用于发热/咳嗽的抗生素存在显著关联。

结果

5岁以下发热/咳嗽且服用抗生素的儿童中,不合格抗生素处方的比例为67.19%(95%CI 66.51至67.85),范围从乍得的40.34%到圣多美和普林西比的92.67%。与城市儿童相比,农村地区5岁以下儿童因发热/咳嗽服用不合格来源处方抗生素的几率高1.23倍(AOR 1.23 [95%CI 1.13至1.33])。母亲具有小学、中学和高等教育的5岁以下儿童因发热/咳嗽服用合格来源处方抗生素的几率分别比母亲未接受正规教育的儿童降低了14%(AOR=0.86 [95%CI 0.79至0.93])、21%(AOR 0.79 [95%CI 0.72至0.86])和21%(AOR 0.79 [95%CI 0.65至0.95])。

结论

该研究表明,在37个SSA国家中,大多数接受抗生素治疗的儿童是从不合格来源获得的。我们的研究结果强调了解决医疗保健差距、改善获得合格医疗保健提供者的机会、促进孕产妇教育以及增强母亲在医疗保健决策中的能力以确保该弱势群体合理使用抗生素的重要性。有必要针对这些因素进行进一步研究和干预,以优化抗生素处方实践并促进5岁以下儿童发热和咳嗽管理中抗生素的合理使用。

相似文献

1
Antibiotic prescription sources and use among under-5 children with fever/cough in sub-Saharan Africa.
Int Health. 2025 Jan 3;17(1):94-104. doi: 10.1093/inthealth/ihae026.
3
Immediate versus delayed versus no antibiotics for respiratory infections.
Cochrane Database Syst Rev. 2023 Oct 4;10(10):CD004417. doi: 10.1002/14651858.CD004417.pub6.
4
Delayed antibiotic prescriptions for respiratory infections.
Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD004417. doi: 10.1002/14651858.CD004417.pub5.
7
Delayed antibiotics for symptoms and complications of respiratory infections.
Cochrane Database Syst Rev. 2004 Oct 18(4):CD004417. doi: 10.1002/14651858.CD004417.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3.

引用本文的文献

1
Social Determinants of Health and Antibiotic Consumption.
Antibiotics (Basel). 2025 May 15;14(5):513. doi: 10.3390/antibiotics14050513.

本文引用的文献

2
What influences parental decisions about antibiotic use with their children: A qualitative study in rural Australia.
PLoS One. 2023 Jul 19;18(7):e0288480. doi: 10.1371/journal.pone.0288480. eCollection 2023.
3
Antibiotic prescription from qualified sources for children with fever/cough: cross-sectional study from 59 low- and middle-income countries.
EClinicalMedicine. 2023 Jun 29;61:102055. doi: 10.1016/j.eclinm.2023.102055. eCollection 2023 Jul.
5
Current Antibiotic Use Among Hospitals in the sub-Saharan Africa Region; Findings and Implications.
Infect Drug Resist. 2023 Apr 13;16:2179-2190. doi: 10.2147/IDR.S398223. eCollection 2023.
8
Taking Opportunities, Taking Medicines: Antibiotic Use in Rural Eastern Uganda.
Med Anthropol. 2022 May-Jun;41(4):418-430. doi: 10.1080/01459740.2022.2047676. Epub 2022 Mar 24.
10
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验